Furthermore, NTERA2-produced lEVs, when incubated with U87 GBM cells, are able to reduce their migration, in a CRIPTO-dependent manner, without inducing cell proliferation and chemioresistance. The gene discussed is CRIPTO; the disease is glioblastoma.